Crescent Grove Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $891K | Buy |
|
|||||
|
2025
Q1 | $717K | Buy |
|
|||||
|
2024
Q4 | $718K | Buy |
|
|||||
|
2024
Q3 | $740K | Buy |
|
|||||
|
2024
Q2 | $668K | Buy |
|
|||||
|
2024
Q1 | $684K | Buy |
|
|||||
|
2023
Q4 | $715K | Sell |
|
|||||
|
2023
Q3 | $607K | Sell |
|
|||||
|
2023
Q2 | $752K | Sell |
|
|||||
|
2023
Q1 | $679K | Hold |
|
|||||
|
2022
Q4 | $638K | Sell |
|
|||||
|
2022
Q3 | $773K | Sell |
|
|||||
|
2022
Q2 | $746K | Buy |
|
|||||
|
2022
Q1 | $902K | Buy |
|
|||||
|
2021
Q4 | $1.15M | Sell |
|
|||||
|
2021
Q3 | $1.45M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Sell |
|
|||||
|
2021
Q1 | $2.28M | Buy |
|
|||||
|
2020
Q4 | $801K | Buy |
|
|||||
|
2020
Q3 | $222K | Buy |
|